AMEDISYS INC (AMED)
US0234361089 - Common Stock
ChartMill assigns a Buy % Consensus number of 71% to AMED. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 99.73. This target is 9.54% above the current price.
AMED was analyzed by 18 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about AMED.
In the previous month the buy percentage consensus was at a similar level.
AMED was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-26 | Raymond James | Maintains | Market Perform -> Market Perform |
| 2024-03-25 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-09-14 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2023-07-31 | TD Cowen | Maintains | Market Perform -> Market Perform |
| 2023-07-27 | Credit Suisse | Reiterate | Neutral -> Neutral |
| 2023-07-06 | Jefferies | Downgrade | Buy -> Hold |
| 2023-06-28 | Benchmark | Downgrade | Buy -> Hold |
| 2023-06-27 | Benchmark | Downgrade | Buy -> Hold |
| 2023-06-27 | Truist Securities | Maintains | Hold -> Hold |
| 2023-06-07 | Truist Securities | Downgrade | Buy -> Hold |
| 2023-06-06 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2023-06-06 | Benchmark | Reiterate | Buy -> Buy |
| 2023-06-06 | Credit Suisse | Downgrade | Outperform -> Neutral |
| 2023-05-08 | TD Cowen | Maintains | Market Perform |
| 2023-05-05 | Barclays | Maintains | Equal-Weight |
| 2023-05-04 | Stephens & Co. | Reiterate | Equal-Weight |
| 2023-05-04 | Truist Securities | Maintains | Buy |
| 2023-04-21 | Cantor Fitzgerald | Initiate | Neutral |
| 2023-04-13 | Truist Securities | Maintains | Buy |
| 2023-03-14 | Benchmark | Reiterate | Buy |
| 2023-03-14 | Stephens & Co. | Reiterate | Equal-Weight |
| 2023-03-13 | Barclays | Initiate | Equal-Weight |
| 2023-02-27 | Credit Suisse | Reiterate | Outperform |
| 2023-02-21 | RBC Capital | Maintains | Outperform |
| 2023-02-16 | Benchmark | Maintains | Buy |
| 2023-02-16 | Stephens & Co. | Reiterate | Equal-Weight |
| 2023-02-13 | Benchmark | Reiterate | Buy |
| 2023-01-25 | Benchmark | Maintains | Buy |
| 2023-01-23 | Credit Suisse | Maintains | Outperform |
| 2023-01-19 | Oppenheimer | Maintains | Outperform |